DAVID P. PERRY - 15 Sep 2022 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Executive Chairman of the Board of Directors, Director, 10%+ Owner
Signature
/s/ Mark Heinen, Attorney-in-Fact for David P. Perry
Issuer symbol
BTTX on OTC
Transactions as of
15 Sep 2022
Net transactions value
+$102,598
Form type
4
Filing time
19 Sep 2022, 06:06:19 UTC
Previous filing
10 Jun 2022
Next filing
12 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $21,623 +10,844 +21% $1.99 62,380 15 Sep 2022 Direct F1
transaction BTTX Common Stock Purchase $80,975 +39,156 +63% $2.07 101,536 16 Sep 2022 Direct F2
holding BTTX Common Stock 293,150 15 Sep 2022 By spouse F3, F4
holding BTTX Common Stock 21,336 15 Sep 2022 By Pensus Limited Trust F3, F5
holding BTTX Common Stock 10,464,015 15 Sep 2022 By David P. Perry 2015 Trust F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.99 to $2.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021.
F4 These shares are owned directly by Mr. Perry's spouse, Georgianna Maule-Ffinch.
F5 These shares are owned directly by Donald R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Georgianna Maule-Ffinch.
F6 These shares are owned directly by the David P. Perry 2015 Trust (the "Perry Trust"), a ten percent owner of Issuer, and indirectly by Mr. Perry as trustee of the Perry Trust. Mr. Perry is an officer, director and ten percent owner of the Issuer.

Remarks:

Executive Chairman of the Board of Directors